BAM
Blueshift Asset Management’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,348
| Closed | -$240K | – | 383 |
|
|
2024
Q4 | $240K | Sell |
1,348
-5,441
| -80% | -$967K | 0.09% | 307 |
|
|
2024
Q3 | $1.34M | Buy |
6,789
+738
| +12% | +$146K | 0.33% | 63 |
|
|
2024
Q2 | $1.04M | Buy |
+6,051
| New | +$1.04M | 0.35% | 70 |
|
|
2024
Q1 | – | Sell |
-5,004
| Closed | -$775K | – | 266 |
|
|
2023
Q4 | $775K | Buy |
+5,004
| New | +$775K | 0.41% | 67 |
|
|
2023
Q3 | – | Sell |
-6,437
| Closed | -$867K | – | 267 |
|
|
2023
Q2 | $867K | Buy |
6,437
+1,577
| +32% | +$212K | 0.33% | 67 |
|
|
2023
Q1 | $775K | Buy |
4,860
+1,751
| +56% | +$279K | 0.32% | 86 |
|
|
2022
Q4 | $502K | Buy |
3,109
+43
| +1% | +$6.95K | 0.23% | 117 |
|
|
2022
Q3 | $411K | Buy |
+3,066
| New | +$411K | 0.09% | 325 |
|
|
2022
Q2 | – | Sell |
-14,808
| Closed | -$2.4M | – | 643 |
|
|
2022
Q1 | $2.4M | Buy |
+14,808
| New | +$2.4M | 0.22% | 125 |
|
|
2021
Q4 | – | Sell |
-9,863
| Closed | -$1.06M | – | 801 |
|
|
2021
Q3 | $1.06M | Sell |
9,863
-164,112
| -94% | -$17.7M | 0.06% | 390 |
|
|
2021
Q2 | $19.6M | Buy |
173,975
+144,589
| +492% | +$16.3M | 1.07% | 9 |
|
|
2021
Q1 | $3.18M | Buy |
29,386
+2,743
| +10% | +$297K | 0.33% | 68 |
|
|
2020
Q4 | $2.86M | Buy |
26,643
+16,253
| +156% | +$1.74M | 0.34% | 75 |
|
|
2020
Q3 | $910K | Buy |
+10,390
| New | +$910K | 0.12% | 225 |
|